• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育异常痣及其他黑色素瘤风险标志物。

Dysplastic nevi and other risk markers for melanoma.

作者信息

Seykora J, Elder D

机构信息

Pigmented Lesion Study Group, University of Pennsylvania School of Medicine, Philadelphia, USA.

出版信息

Semin Oncol. 1996 Dec;23(6):682-7.

PMID:8970587
Abstract

Risk markers for cancer are genetic or behavioral attributes that are statistically associated with increased incidence of cancer. Risk may be assessed either in case-control studies, or in cohort studies in which individuals with particular attributes are followed and cancer risk is determined by direct observation. Both of these methods have been used to determine the major risk markers for melanoma. The single most important risk marker is the presence on the skin of dysplastic nevi. Dysplastic nevi may be regarded as intermediate lesions of tumor progression, in that approximately 30% of melanomas arise in association with a precursor nevus, which is most commonly dysplastic. However, paradoxically, because they are vastly more numerous than melanoma, most dysplastic nevi are stable lesions that do not progress. Additional important melanoma risk factors include a family and/or personal history of melanoma. A third major category of risk markers includes indicators of acute and chronic exposure to the sun, including freckles, actinic skin damage, and a history of sunburn. Evaluation of these markers in oncological patients and their first-degree relatives can identify a population of individuals whose risk for melanoma ranges from several-fold to more than 100-fold greater than that of random population members. Efforts directed at early diagnosis in these individuals can result in recognition of melanomas in their early, curable stages.

摘要

癌症风险标志物是与癌症发病率增加在统计学上相关的遗传或行为属性。风险可以在病例对照研究中评估,也可以在队列研究中评估,在队列研究中,对具有特定属性的个体进行随访,并通过直接观察确定癌症风险。这两种方法都已被用于确定黑色素瘤的主要风险标志物。最重要的单一风险标志物是发育异常痣在皮肤上的存在。发育异常痣可被视为肿瘤进展的中间病变,因为大约30%的黑色素瘤与前驱痣相关,最常见的是发育异常痣。然而,矛盾的是,由于发育异常痣比黑色素瘤多得多,大多数发育异常痣是稳定的病变,不会进展。其他重要的黑色素瘤风险因素包括黑色素瘤的家族史和/或个人史。第三大类风险标志物包括急性和慢性日晒的指标,包括雀斑、光化性皮肤损伤和晒伤史。对肿瘤患者及其一级亲属的这些标志物进行评估,可以识别出一群黑色素瘤风险比随机人群高出几倍至100多倍的个体。针对这些个体进行早期诊断的努力可以在黑色素瘤的早期可治愈阶段识别出它们。

相似文献

1
Dysplastic nevi and other risk markers for melanoma.发育异常痣及其他黑色素瘤风险标志物。
Semin Oncol. 1996 Dec;23(6):682-7.
2
Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.前瞻性随访中黑色素瘤发病的危险因素。非典型(发育异常)痣的重要性。
Arch Dermatol. 1994 Aug;130(8):1002-7.
3
Melanoma risk in individuals with clinically atypical nevi.患有临床非典型痣个体的黑色素瘤风险
Arch Dermatol. 1994 Aug;130(8):999-1001.
4
Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.使用基线图像和皮肤镜检查在黑色素瘤高危患者中检测到的新痣和变化痣及黑色素瘤的发病率。
Arch Dermatol. 2005 Aug;141(8):998-1006. doi: 10.1001/archderm.141.8.998.
5
Dysplastic nevi and malignant melanoma.发育异常痣与恶性黑色素瘤。
Am Fam Physician. 1990 Aug;42(2):372-85.
6
Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.发育异常痣作为散发性(非家族性)黑色素瘤的风险标志物。一项病例对照研究。
Arch Dermatol. 1991 Jul;127(7):995-9.
7
Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.对有皮肤黑素瘤和发育异常痣综合征遗传易感性的家族进行监测:一项瑞典预防计划的结果。
J Clin Oncol. 2007 Jul 1;25(19):2819-24. doi: 10.1200/JCO.2007.11.4108.
8
MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.地中海人群散发性和家族性黑色素瘤中的MC1R、ASIP与DNA修复
J Natl Cancer Inst. 2005 Jul 6;97(13):998-1007. doi: 10.1093/jnci/dji176.
9
Dysplastic nevi in relation to superficial spreading melanoma.发育异常痣与浅表扩散性黑色素瘤的关系。
Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr;2(2):99-101.
10
A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.黑色素瘤和发育异常痣的自然史:易患黑色素瘤家族的病变图谱。
Cancer. 2002 Jun 15;94(12):3192-209. doi: 10.1002/cncr.10605.

引用本文的文献

1
BRAF V600E Immunohistochemistry Predicts Prognosis of Patients with Cutaneous Melanoma in Thai population.BRAF V600E免疫组化可预测泰国人群皮肤黑色素瘤患者的预后。
Plast Reconstr Surg Glob Open. 2022 Oct 24;10(10):e4605. doi: 10.1097/GOX.0000000000004605. eCollection 2022 Oct.
2
Cutaneous melanoma: From pathogenesis to therapy (Review).皮肤黑色素瘤:从发病机制到治疗(综述)。
Int J Oncol. 2018 Apr;52(4):1071-1080. doi: 10.3892/ijo.2018.4287. Epub 2018 Feb 27.
3
Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi.
Nodal、Cripto-1和Notch4在成人痣中的转化意义。
Oncol Lett. 2016 Aug;12(2):1349-1354. doi: 10.3892/ol.2016.4755. Epub 2016 Jun 21.
4
Genetics of melanocytic nevi.黑素细胞痣的遗传学
Pigment Cell Melanoma Res. 2015 Nov;28(6):661-72. doi: 10.1111/pcmr.12412.
5
Genome-wide analysis of gene and protein expression of dysplastic naevus cells.发育异常痣细胞的基因和蛋白质表达的全基因组分析。
J Skin Cancer. 2012;2012:981308. doi: 10.1155/2012/981308. Epub 2012 Nov 28.
6
Embryonic signaling in melanoma: potential for diagnosis and therapy.胚胎信号在黑色素瘤中的作用:潜在的诊断和治疗价值。
Lab Invest. 2011 Jun;91(6):819-24. doi: 10.1038/labinvest.2011.63. Epub 2011 Apr 4.
7
B-Raf specific antibody responses in melanoma patients.黑色素瘤患者中针对B-Raf的特异性抗体反应。
BMC Cancer. 2004 Sep 12;4:62. doi: 10.1186/1471-2407-4-62.